The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Blood vessel maturation: vascular development comes of age
Open accessAbstract
What are the cellular and molecular mechanisms that regulate new vessel formation and maturation? This question identifies several fundamental issues of vascular biology related to the development of the vasculature via vasculogenesis and angiogenesis. Early investigations of vasculature were largely descriptive (1, 2). The advent of methods for the isolation and maintenance of vascular cells in tissue culture led to assay systems aimed at recreating the initial events of the angiogenic process, including endothelial cell protease production, migration and proliferation. However, less attention has been directed to the later stages of vascularization, such as investment of vessels with mural cells (pericytes or smooth muscle cells), production of basement membrane, induction of vessel bed specializations or the process of vascular regression. The final stages of vessel formation might also be referred to as “remodeling” and appear to define a process through which a forming vasculature becomes a stable, mature vessel bed. These steps may also be taken advantage of to develop antitumor strategies, as suggested by Benjamin et al. in this issue (3). What regulates the phenotypic changes that occur between forming and mature vessels? A number of clinical and experimental observations support the concept that the association between the vascular tube and the mural cells mediates vessel stabilization or maturation. Ultrastructural studies of vascularization during wound healing revealed a temporal correlation between pericyte investment of the capillary and the cessation of vessel growth. This observation led the authors of this study to state: “The incorporation of pericytes within the basement membrane of proliferating capillaries is proposed as the mechanism for inhibition of capillary proliferation” (4). Clinical observations are consistent with a role for mural cells in stabilizing vessels. The vessel proliferation that characterizes proliferative diabetic retinopathy is preceded by a stage characterized by the selective loss of pericytes (5). Similarly, the new vessels that form as a complication of the retinopathy of prematurity arise from immature microvessels that have yet to be invested by pericytes (6). Thus, the physical association between the nascent vascular tube and mural cells appears to signal vessel stabilization. Earlier work from Stone and Keshet indicates that vessels are dependent upon exogenous survival factors, e.g., VEGF (7) (Fig. (Fig.1),1), for a critical period of time during their development. The current study by Benjamin et al. in this issue (3) further suggests that the association of forming vessels with the mural cells marks the end of this period of growth factor dependence. Two aspects of vessel stabilization are addressed in this study. The first is that in the absence of associated pericytes or smooth muscle cells, the nascent endothelial cell tube is unstable and is prone to regression. The second is the notion that the nascent endothelial tube requires VEGF for survival. In normal development, the time for overlap of these events is terminated by the arrival of the mural cells. The tumor vasculature, on the other hand, appears to be trapped in a cycle where high levels of growth factors can induce and sustain immature vessels in the relative absence of mural cells. The chronic immaturity of tumor vessels has led Dvorak to characterize a tumor as a “wound that never heals” (8). At the same time, these features make tumor vessels viable targets for antitumor therapies. Benjamin et al. (3) demonstrate that removal of growth factors leads not only to the cessation of new vessel growth, but also to regression of the immature tumor vasculature (3). Figure 1 Vessel maturation: vessel development proceeds from a stage of growth-factor dependence where loss of a survival factor leads to apoptosis. Vessel stabilization is marked by investment with mural cells, local activation of TGF-β, and basement ... Although recent evidence suggests that endothelial cell–mural cell contact and VEGF-dependence are pivotal junctures during vessel maturation, questions regarding the molecular basis of vessel maturation remains unanswered. Using tissue culture models, we have previously shown that endothelial cells recruit mural cell precursors via the secretion of PDGF-BB. Consistent with this prediction, mice null for PDGF B lack pericytes in some microvascular beds (10). Furthermore, coculture studies reveal that endothelial cell–mural cell contact leads to the activation of TGF-β (9, 11), a pleiotrophic growth factor that has been shown to mediate differentiation of a variety of cell types. In the context of the microvasculature, we speculate that TGF-β functions at multiple steps leading to vessel stabilization, including inhibition of endothelial cell proliferation and migration, as well as induction of pericyte/smooth muscle cell differentiation (12) (Fig. (Fig.1).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Transforming growth factor beta
(2011) · SpringerReference · doi:10.1007/springerreference_39918 · Cited by 1,944
Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., & Keshet, E. (1995) · Nature Medicine · doi:10.1038/nm1095-1024 · Cited by 1,604
The Molecular and Cellular Biology of Wound Repair
(1988) · Springer eBooks · doi:10.1007/978-1-4615-1795-5 · Cited by 1,516
Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., & Keshet, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5028 · Cited by 1,241
Blood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215
Self-citationHirschi, K. K., Rohovsky, S. A., & D'Amore, P. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.3.805 · Cited by 796
Self-citationAntonelli-Orlidge, A., Saunders, K. B., Smith, S. R., & D'Amore, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4544 · Cited by 757
Self-citationVascular development: cellular and molecular regulation
Beck, L., & D'Amore, P. A. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141503 · Cited by 519
Self-citationRegulation of myogenic differentiation by type beta transforming growth factor.
Olson, E. N., Sternberg, E., Hu, J. S., Spizz, G., & Wilcox, C. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.5.1799 · Cited by 399
Microscopic observations on the growth of blood capillaries in the living mammal
Clark, E. R., & Clark, E. L. (1939) · American Journal of Anatomy · doi:10.1002/aja.1000640203 · Cited by 370
Early organogenesis of the kidney
Sax�n, L., & Sariola, H. (1987) · Pediatric Nephrology · doi:10.1007/bf00849241 · Cited by 366
Hirschi, K. K., Rohovsky, S. A., Beck, L. H., Smith, S. R., & D’Amore, P. A. (1999) · Circulation Research · doi:10.1161/01.res.84.3.298 · Cited by 340
Self-citationCunha, G. R. (1994) · Cancer · doi:10.1002/1097-0142(19940801)74:3+<1030::aid-cncr2820741510>3.0.co;2-q · Cited by 328
Ausprunk, D. H., Knighton, D. R., & Folkman, J. (1974) · Developmental Biology · doi:10.1016/0012-1606(74)90004-9 · Cited by 300
Role of the pericyte in wound healing
Crocker, D. J., Murad, T. M., & Geer, J. C. (1970) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(70)90084-5 · Cited by 218
Neurotrophin receptors: mediators of life and death
Chao, M., Casaccia-Bonnefil, P., Carter, B., Chittka, A., Kong, H., & Yoon, S. O. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00036-2 · Cited by 159
O’Reilly, M. A., Stripp, B. R., & Pryhuber, G. (1997) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19970901)38:5<473::aid-jemt3>3.0.co;2-j · Cited by 24
Cited by
Polymeric system for dual growth factor delivery
Richardson, T. P., Peters, M. C., Ennett, A. B., & Mooney, D. J. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1029 · Cited by 1,752
Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors
Yamashita, J., Itoh, H., Hirashima, M., Ogawa, M., Nishikawa, S., Yurugi, T., Naito, M., Nakao, K., & Nishikawa, S.-I. (2000) · Nature · doi:10.1038/35040568 · Cited by 1,348
Regenerative medicine: Current therapies and future directions
Mao, A. S., & Mooney, D. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508520112 · Cited by 941
Targeting the tumour vasculature: insights from physiological angiogenesis
Chung, A. S., Lee, J., & Ferrara, N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2868 · Cited by 752
Erber, R., Thurnher, A., D. Katsen, A., Groth, G., Kerger, H., Hammes, H., D. Menger, M., Ullrich, A., & Vajkoczy, P. (2004) · The FASEB Journal · doi:10.1096/fj.03-0271fje · Cited by 610
Metadata
- Authors
- Darland, D. C., & D’Amore, P. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-01-15
- Volume
- 103
- Issue
- 2
- Pages
- 157-158
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2076746552
- Cited by
- 335
- References
- 19
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.